Cargando…
VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition
The use of computational tools for virtual screening provides a cost-efficient approach to select starting points for drug development. We have developed VSpipe, a user-friendly semi-automated pipeline for structure-based virtual screening. VSpipe uses the existing tools AutoDock and OpenBabel toget...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017540/ https://www.ncbi.nlm.nih.gov/pubmed/29414924 http://dx.doi.org/10.3390/molecules23020353 |
_version_ | 1783334773356232704 |
---|---|
author | Álvarez-Carretero, Sandra Pavlopoulou, Niki Adams, James Gilsenan, Jane Tabernero, Lydia |
author_facet | Álvarez-Carretero, Sandra Pavlopoulou, Niki Adams, James Gilsenan, Jane Tabernero, Lydia |
author_sort | Álvarez-Carretero, Sandra |
collection | PubMed |
description | The use of computational tools for virtual screening provides a cost-efficient approach to select starting points for drug development. We have developed VSpipe, a user-friendly semi-automated pipeline for structure-based virtual screening. VSpipe uses the existing tools AutoDock and OpenBabel together with software developed in-house, to create an end-to-end virtual screening workflow ranging from the preparation of receptor and ligands to the visualisation of results. VSpipe is efficient and flexible, allowing the users to make choices at different steps, and it is amenable to use in both local and cluster mode. We have validated VSpipe using the human protein tyrosine phosphatase PTP1B as a case study. Using a combination of blind and targeted docking VSpipe identified both new and known functional ligand binding sites. Assessment of different binding clusters using the ligand efficiency plots created by VSpipe, defined a drug-like chemical space for development of PTP1B inhibitors with potential applications to other PTPs. In this study, we show that VSpipe can be deployed to identify and compare different modes of inhibition thus guiding the selection of initial hits for drug discovery. |
format | Online Article Text |
id | pubmed-6017540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60175402018-11-13 VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition Álvarez-Carretero, Sandra Pavlopoulou, Niki Adams, James Gilsenan, Jane Tabernero, Lydia Molecules Article The use of computational tools for virtual screening provides a cost-efficient approach to select starting points for drug development. We have developed VSpipe, a user-friendly semi-automated pipeline for structure-based virtual screening. VSpipe uses the existing tools AutoDock and OpenBabel together with software developed in-house, to create an end-to-end virtual screening workflow ranging from the preparation of receptor and ligands to the visualisation of results. VSpipe is efficient and flexible, allowing the users to make choices at different steps, and it is amenable to use in both local and cluster mode. We have validated VSpipe using the human protein tyrosine phosphatase PTP1B as a case study. Using a combination of blind and targeted docking VSpipe identified both new and known functional ligand binding sites. Assessment of different binding clusters using the ligand efficiency plots created by VSpipe, defined a drug-like chemical space for development of PTP1B inhibitors with potential applications to other PTPs. In this study, we show that VSpipe can be deployed to identify and compare different modes of inhibition thus guiding the selection of initial hits for drug discovery. MDPI 2018-02-07 /pmc/articles/PMC6017540/ /pubmed/29414924 http://dx.doi.org/10.3390/molecules23020353 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Álvarez-Carretero, Sandra Pavlopoulou, Niki Adams, James Gilsenan, Jane Tabernero, Lydia VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition |
title | VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition |
title_full | VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition |
title_fullStr | VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition |
title_full_unstemmed | VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition |
title_short | VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition |
title_sort | vspipe, an integrated resource for virtual screening and hit selection: applications to protein tyrosine phospahatase inhibition |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017540/ https://www.ncbi.nlm.nih.gov/pubmed/29414924 http://dx.doi.org/10.3390/molecules23020353 |
work_keys_str_mv | AT alvarezcarreterosandra vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition AT pavlopoulouniki vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition AT adamsjames vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition AT gilsenanjane vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition AT tabernerolydia vspipeanintegratedresourceforvirtualscreeningandhitselectionapplicationstoproteintyrosinephospahataseinhibition |